Ultrasound image-guided radiation therapy (IGRT) developer Resonant Medical will showcase the next generation of its Clarity IGRT system at this week's European Society for Therapeutic Radiology and Oncology (ESTRO) annual meeting in Maastricht, Netherlands.
The new version supports adaptive radiation therapy for soft-tissue cancers, alerting physicians of changes in a target structure's precise location, shape, and size, according to the Montreal-based firm. Users can then utilize the information to adapt the patient's treatment plan.
The Maastro Clinic in Maastricht has begun offering Clarity for prostate and breast cancer treatments, Resonant said.
Related Reading
Varian duels with Resonant over patents, December 22, 2005
Resonant raises more than $20 million, December 15, 2005
Resonant gets 510(k), December 21, 2004
New financing for Resonant, October 7, 2004
Copyright © 2009 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
